The Whirl of Wound Care

However irksome it may be to think about open or healing wounds, the medical advances and market potential in this niche space is quite appealing for investors. Globally, there are 50 million reported cases of patients suffering from some type of wound that may be difficult to close or heal.

Read more »

SpectraScience: Innovations in Cancer Detection

SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.

Read more »

OneMedForum Recap: Del Mar Pharmaceuticals

Delmar Pharmaceuticals (DMPI) is a clinical and early stage Oncologyl Company focused on developing and commercializing leading anti-cancer therapies in high impact orphan oncological indications specifically where patients have failed contemporary therapy.

Read more »

OneMedForum Recap: Pressure Biosciences

Pressure Biosciences (PBIO) is a life sciences company centered on developing and commercializing a novel technology titled Pressure Cycling Technology (PCT).

Read more »

The Fly on the Wall: Athersys Publishes Study on Increasing Survival of Organ Transplants With Stem Cells

Athersys (ATHX) is a clinical stage based biopharmaceutical company with an exponentially growing pipeline and an array of products in therapeutics to treat significant and life-threatening diseases.

Read more »

PR Newswire: BioDelivery Sciences International Secures $20 Million in Debt Financing

A company to keep a look out for in the upcoming future is BioDelivery Sciences International (BDSI), a specialty pharmaceutical company with a platform of drug delivery technologies to develop, commercialize, and improve already proven applications of therapeutics.

Read more »

Global News Wire: Pluristem Therapeutics Forms Strategic Alliance with ChaBio & Diostech

Pluristem Therapeutics (PSTI) is a developer of placenta-based cell therapies. They have just formed a strategic alliance with Cha Bio&Diostech.

Read more »

Global News Wire: Novavax Initiating Human Clinical Trials for H7N9 Virus

Novavax, Inc (NVAX) is a clinical-stage biopharmaceutical company that strives to create novel vaccines to treat a broad spectrum of diseases around the world.

Read more »

Pharma Live: Cytokinetics amending errors in Amyotrophic Lateral Sclerosis Phase IIB Study

Cytokinetics (CYTK) is a clinical stage biotechnology company that focuses on the discovery and development of novel molecular therapeutics in relation to muscle function.

Read more »

BioCentury: Orexo is Dissolving Away Opioid Addiction with New Medication

Orexo is an emerging specialty pharmaceutical company in route to enter the market with their new medication Zubsolv; an oral medication that dissolves under the tongue to treat opioid addiction.

Read more »